0001214659-20-007257.txt : 20200817
0001214659-20-007257.hdr.sgml : 20200817
20200817162451
ACCESSION NUMBER: 0001214659-20-007257
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200813
FILED AS OF DATE: 20200817
DATE AS OF CHANGE: 20200817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniels Mark
CENTRAL INDEX KEY: 0001753840
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 201110430
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-49453.xml
PRIMARY DOCUMENT
X0306
4
2020-08-13
0001581280
Twist Bioscience Corp
TWST
0001753840
Daniels Mark
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
See Remarks
Common Stock
2020-08-13
4
M
false
14502
5.95
A
68220
D
Common Stock
2020-08-13
4
S
false
7500
65.00
D
60720
D
Common Stock
2020-08-13
4
S
false
7002
64.03
D
53718
D
Common Stock
2020-08-14
4
M
false
9006
5.95
A
62724
D
Common Stock
2020-08-14
4
S
false
7500
66.00
D
55224
D
Common Stock
2020-08-14
4
S
false
1506
67.00
D
53718
D
Employee Stock Option (right to buy)
5.95
2020-08-13
4
M
false
14502
0
D
2026-08-29
Common Stock
14502
40878
D
Employee Stock Option (right to buy)
5.95
2020-08-14
4
M
false
9006
0
D
2026-08-29
Common Stock
9006
31872
D
The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer, and Secretary
/s/ William Solis, as Attorney-in-Fact for Mark Daniels
2020-08-17